H-1B sponsorCTFEIN 13-2686668Updated Jul 2026
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
US H-1B Labor Condition Application activity for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.. Filed 395 disclosures between FY2010 and FY2026 from worksites with a CT headquarters indicator.
Total filings
9
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026
H-1B outcome breakdown
Share of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 93.9% |
| Cert-withdrawn | 3.0% |
| Withdrawn | 2.5% |
| Denied | 0.5% |
Certified93.9%
Cert-withdrawn3.0%
Withdrawn2.5%
Denied0.5%
Top occupations sponsored
SOC codes filed most by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 15-2041 | Statisticians | 86 |
| 2 | 15-2051 | Data Scientists | 54 |
| 3 | 19-2031 | Chemists | 43 |
| 4 | 19-1042 | Medical Scientists, Except Epidemiologists | 30 |
| 5 | 19-1022 | Microbiologists | 26 |
| 6 | 19-1029 | Biological Scientists, All Other | 25 |
| 7 | 15-1221 | Computer and Information Research Scientists | 16 |
| 8 | 19-1021 | Biochemists and Biophysicists | 11 |
| 9 | 11-9111 | Medical and Health Services Managers | 8 |
| 10 | 15-1299 | Computer Occupations, All Other | 7 |
Statisticians
86
Data Scientists
54
Chemists
43
Medical Scientists, Except Epidemiologists
30
Microbiologists
26
Biological Scientists, All Other
25
Computer and Information Research Scientists
16
Biochemists and Biophysicists
11
Medical and Health Services Managers
8
Computer Occupations, All Other
7
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 26 |
| FY2011 | 31 |
| FY2012 | 25 |
| FY2013 | 16 |
| FY2014 | 25 |
| FY2015 | 19 |
| FY2016 | 25 |
| FY2017 | 25 |
| FY2018 | 23 |
| FY2019 | 43 |
| FY2020 | 8 |
| FY2021 | 11 |
| FY2022 | 15 |
| FY2023 | 6 |
| FY2024 | 42 |
| FY2025 | 46 |
| FY2026 | 9 |
| Period | Value |
|---|---|
| FY2010 | 26 |
| FY2011 | 31 |
| FY2012 | 25 |
| FY2013 | 16 |
| FY2014 | 25 |
| FY2015 | 19 |
| FY2016 | 25 |
| FY2017 | 25 |
| FY2018 | 23 |
| FY2019 | 43 |
| FY2020 | 8 |
| FY2021 | 11 |
| FY2022 | 15 |
| FY2023 | 6 |
| FY2024 | 42 |
| FY2025 | 46 |
| FY2026 | 9 |
Compare BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.
Understand the data
Definitions and methodology behind these H-1B figures.